Biochemical correlates of neuropsychiatric illness in maple syrup urine disease
Open Access
- 8 March 2013
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 123 (4), 1809-1820
- https://doi.org/10.1172/jci67217
Abstract
Maple syrup urine disease (MSUD) is an inherited disorder of branched chain amino acid metabolism presenting with neonatal encephalopathy, episodic metabolic decompensation, and chronic amino acid imbalances. Dietary management enables survival and reduces risk of acute crises. Liver transplantation has emerged as an effective way to eliminate acute decompensation risk. Psychiatric illness is a reported MSUD complication, but has not been well characterized and remains poorly understood. We report the prevalence and characteristics of neuropsychiatric problems among 37 classical MSUD patients (ages 5–35 years, 26 on dietary therapy, 11 after liver transplantation) and explore their underlying mechanisms. Compared with 26 age-matched controls, MSUD patients were at higher risk for disorders of cognition, attention, and mood. Using quantitative proton magnetic resonance spectroscopy, we found lower brain glutamate, N-acetylaspartate (NAA), and creatine concentrations in MSUD patients, which correlated with specific neuropsychiatric outcomes. Asymptomatic neonatal course and stringent longitudinal biochemical control proved fundamental to optimizing long-term mental health. Neuropsychiatric morbidity and neurochemistry were similar among transplanted and nontransplanted MSUD patients. In conclusion, amino acid dysregulation results in aberrant neural networks with neurochemical deficiencies that persist after transplant and correlate with neuropsychiatric morbidities. These findings may provide insight into general mechanisms of psychiatric illness.Keywords
This publication has 51 references indexed in Scilit:
- Liver Transplantation for Classical Maple Syrup Urine Disease: Long-Term Follow-Up in 37 Patients and Comparative United Network for Organ Sharing ExperienceThe Journal of Pediatrics, 2012
- Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: A case seriesPediatric Transplantation, 2010
- Classical maple syrup urine disease and brain development: Principles of management and formula designMolecular Genetics and Metabolism, 2009
- 1H MRS allows brain phenotype differentiation in sisters with late onset ornithine transcarbamylase deficiency (OTCD) and discordant clinical presentationsMolecular Genetics and Metabolism, 2008
- Dual mechanism of brain injury and novel treatment strategy in maple syrup urine diseaseBrain, 2008
- A Fully Automated Method for Tissue Segmentation and CSF-Correction of Proton MRSI Metabolites Corroborates Abnormal Hippocampal NAA in SchizophreniaNeuroImage, 2002
- Interrelationships of Leucine and Glutamate Metabolism in Cultured AstrocytesJournal of Neurochemistry, 1994
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993
- Abnormal dendritic development in maple syrup urine diseasePediatric Neurology, 1992
- Intellectual outcome in children with maple syrup urine diseaseThe Journal of Pediatrics, 1991